Company News
Re:Pair Genomics Places Top 4 in Digital Health Tech Stream at EPIC 2025
We are proud to share that Re:Pair Genomics placed in the Top 4 of the Digital Health Technology stream at EPIC 2025, one of…
March 2026Read More →
Latest Updates
News & Insights
Company News
Spark Night at Rotman (REVCA)
Our CEO shared what we’ve been building and what’s ahead at Spark Night, hosted by the Rotman Entrepreneurship and Venture Capital Association (REVCA).
March 2026Read More →
Company News
Canada–Korea AI x Life Sciences Innovation Forum
Re:Pair Genomics joined the CLIP–PDA Mission to Korea and the Canada–Korea AI x Life Sciences Innovation Forum to explore collaboration at the intersection of…
March 2026Read More →
Company News
US Provisional Patent Filed (CNS Promoters)
Filed a US provisional patent for 30+ CNS-related promoters. This milestone is now reflected on our Product page.
January 2026Read More →
Company News
Awarded $105,000 Mitacs Grant
Awarded a Mitacs grant worth $105,000 for the project titled “Designing Cross-Species-Reactive Compact Promoters for Targeting Specific Cell Types in the Body.”
November 2025Read More →
Company News
EPIC 2025
We’re thrilled to announce that Re:pair Genomics has made it to the top 100 semi-finalists for Elevator Pitch International Competition (EPIC) 2025 in Hong…
August 2025Read More →
Company News
UTEST 2025-2026
We are excited to announce that we’ve been accepted into the 2025-2026 cohort of UTEST! UTEST is University of Toronto Early Stage Technology incubator…
July 2025Read More →
Company News
First Look Pitch Competition – Altitude Accelerator
We competed in the First Look Pitch Competition hosted by Altitude Accelerator, making it all the way to the semifinals! We are grateful for…
July 2025Read More →
Company News
CABHI Ignite Program
We are excited to announce that we have been accepted into the Center for Aging + Brain Health Innovation’s Ignite Program, which provides funding…
July 2025Read More →
Company News
Desjardins Startup Prize Pitch Competition
In March 2025 we competed in the Desjardins Startup Prize Pitch Competition, and we are pleased to announce that we placed 3rd in the…
July 2025Read More →
Company News
Tech@RBC Momentum Grant Recipient
We’re pleased to be awarded the Tech@RBC Momentum Grant, which provides support for early-stage tech startups! This initiative is delivered by U of T…
July 2025Read More →
Company News
i.d.e.a. Fund Recipient
We’re pleased to be named as one of the TechAlliance-supported companies in Cohort 3 of i.d.e.a. Fund! This program is funded by the Government…
December 2024Read More →
Company News
Re:Pair Genomics Team Competed in the Hult Prize semifinals in Monterrey, Mexico
In June 2024, we competed in the Hult Prize Semifinals in Mexico. After the preliminary round, Re:Pair Genomics was selected as one of the…
September 2024Read More →
Company News
Re:Pair Genomics Showcases Technology at MaRS Impact Health 2024
On June 13, 2024, Re:Pair Genomics was invited to present and feature our venture in the Biotech Expo Stage, organized by MaRS Impact Health…
June 2024Read More →
Company News
Re:Pair shines in 2nd place at BBTV pitch competition
Building a BioTech Venture, otherwise known as BBTV, is a program offered at the University of Toronto (UofT), by Medicine by Design. Medicine by…
March 2024Read More →
Company News
Hult Prize Competition: A Day of Innovation and Achievement
On 21st February 2024, our team embarked on an extraordinary journey to participate in the prestigious Hult Prize competition, a global platform known for…
March 2024Read More →
Company News
Re:Pair Genomics Presents Poster at the UofT AI Conference
Our team had an incredible day at ConferenceX, held in the MaRS Discovery District! 🚀 The event was truly inspiring, filled with stories from…
January 2024Read More →
Company News
Re:Pair Genomics Presents Poster at the Cell & Gene Therapy West Coast Symposium
On September 7, California Life Sciences and Johnson & Johnson Innovation co-hosted a West Coast Symposium focusing on Cell and Gene Therapy – Advancing…
September 2023Read More →
Research
In silico prediction and in vivo testing of promoters targeting GABAergic inhibitory neurons
Impairment of GABAergic inhibitory neuronal function is linked to epilepsy and other neurological and psychiatric disorders. Recombinant adeno-associated virus (rAAV)-based gene therapy targeting GABAergic…
February 2023Read More →
Company News
Pitch Perfect 2022 Recap & Winners Announcement
On Wednesday November 9th, 2022, H2i welcomed founders, students, faculty, mentors and more to Pitch Perfect 2022! Marking H2i’s first in-person event since early…
November 2022Read More →
Company News
Hatchery NEST 2022 Demo Day
Over 90% of gene therapy clinical trials fail at the moment. The reasons for failure include adverse effects and low efficacy of the treatment.…
September 2022Read More →
Company News
Re:Pair Therapeutics Finalists
Finalists in the Termis Americas Annual Conference and Exhibition.
July 2022Read More →